Iovance Biotherapeutics Inc (IOVA)
10.08
-0.24
(-2.37%)
USD |
NASDAQ |
May 23, 10:04
Iovance Biotherapeutics Free Cash Flow (Quarterly): -126.45M for March 31, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -126.45M |
| December 31, 2023 | -87.50M |
| September 30, 2023 | -87.66M |
| June 30, 2023 | -103.47M |
| March 31, 2023 | -105.48M |
| December 31, 2022 | -80.69M |
| September 30, 2022 | -65.04M |
| June 30, 2022 | -82.21M |
| March 31, 2022 | -85.24M |
| December 31, 2021 | -61.42M |
| September 30, 2021 | -67.38M |
| June 30, 2021 | -63.62M |
| March 31, 2021 | -73.10M |
| December 31, 2020 | -86.03M |
| September 30, 2020 | -58.36M |
| June 30, 2020 | -41.61M |
| March 31, 2020 | -65.93M |
| December 31, 2019 | -57.25M |
| September 30, 2019 | -43.42M |
| June 30, 2019 | -35.23M |
| March 31, 2019 | -29.91M |
| December 31, 2018 | -31.84M |
| September 30, 2018 | -28.39M |
| June 30, 2018 | -24.34M |
| March 31, 2018 | -17.87M |
| Date | Value |
|---|---|
| December 31, 2017 | -20.91M |
| September 30, 2017 | -21.71M |
| June 30, 2017 | -17.52M |
| March 31, 2017 | -19.60M |
| December 31, 2016 | -12.90M |
| September 30, 2016 | -12.93M |
| June 30, 2016 | -3.802M |
| March 31, 2016 | -4.554M |
| December 31, 2015 | -6.731M |
| September 30, 2015 | -3.915M |
| June 30, 2015 | -4.637M |
| March 31, 2015 | -4.241M |
| December 31, 2014 | -4.74M |
| September 30, 2014 | -1.890M |
| June 30, 2014 | -1.324M |
| March 31, 2014 | -2.271M |
| December 31, 2013 | -2.252M |
| September 30, 2013 | -0.4398M |
| June 30, 2013 | -0.6819M |
| March 31, 2013 | -0.30M |
| December 31, 2012 | 0.00 |
| September 30, 2012 | -0.2807M |
| June 30, 2012 | -1.200M |
| March 31, 2012 | -0.7602M |
| December 31, 2011 | -2.720M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-126.45M
Minimum
Mar 2024
-35.23M
Maximum
Jun 2019
-73.85M
Average
-70.24M
Median
Free Cash Flow (Quarterly) Benchmarks
| Viatris Inc | 563.80M |
| Perspective Therapeutics Inc | 4.776M |
| Electromed Inc | 1.222M |
| Xtant Medical Holdings Inc | -6.528M |
| Asensus Surgical Inc | -14.01M |